Literature DB >> 18385132

The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation.

Ronald Carnemolla1, Xuefeng Ren, Tapan K Biswas, Stephen C Meredith, Catherine A Reardon, Jianjun Wang, Godfrey S Getz.   

Abstract

Humans have two major high density lipoprotein (HDL) sub-fractions, HDL(2) and HDL(3), whereas mice have a monodisperse HDL profile. Epidemiological evidence has suggested that HDL(2) is more atheroprotective; however, currently there is no direct experimental evidence to support this postulate. The amino acid sequence of apoA-I is a primary determinant of HDL subclass formation. The majority of the alpha-helical repeats in human apoA-I are proline-punctuated. A notable exception is the boundary between helices 7 and 8, which is located in the transitional segment between the stable N-terminal domain and the C-terminal hydrophobic domain. In this study we ask whether the substitution of a proline-containing sequence (PCS) separating other helices in human apoA-I for the non-proline-containing sequence (NPCS) between helices 7 and 8 (residues 184-190) influences HDL subclass association. The human apoA-I mutant with PCS2 replacing NPCS preferentially bound to HDL(2). In contrast, the mutant where PCS3 replaced NPCS preferentially associated with HDL(3). Thus, the specific amino acid sequence between helices 7 and 8 influences HDL subclass association. The wild-type and mutant proteins exhibited similar physicochemical properties except that the two mutants displayed greater lipid-associated stability versus wild-type human apoA-I. These results focus new attention on the influence of the boundary between helices 7 and 8 on the properties of apoA-I. The expression of these mutants in mice may result in the preferential generation of HDL(2) or HDL(3) and allow us to examine experimentally the anti-atherogenicity of the HDL subclasses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385132      PMCID: PMC2414305          DOI: 10.1074/jbc.M710244200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Apolipoprotein A-I: structure-function relationships.

Authors:  P G Frank; Y L Marcel
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

2.  ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.

Authors:  N Wang; D L Silver; C Thiele; A R Tall
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

3.  Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination.

Authors:  Xuefeng Ren; Lei Zhao; Arun Sivashanmugam; Yi Miao; Leslie Korando; Zhengrong Yang; Catherine A Reardon; Godfrey S Getz; Christie G Brouillette; W Gray Jerome; Jianjun Wang
Journal:  Biochemistry       Date:  2005-11-15       Impact factor: 3.162

4.  Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure.

Authors:  Kristi L Lazar; Hélène Miller-Auer; Godfrey S Getz; Joseph P R O Orgel; Stephen C Meredith
Journal:  Biochemistry       Date:  2005-09-27       Impact factor: 3.162

5.  Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution.

Authors:  Erica J Reschly; Mary G Sorci-Thomas; W Sean Davidson; Stephen C Meredith; Catherine A Reardon; Godfrey S Getz
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

6.  In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.

Authors:  C A Reardon; H Y Kan; V Cabana; L Blachowicz; J R Lukens; Q Wu; K Liadaki; G S Getz; V I Zannis
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

Review 7.  Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles.

Authors:  Anthony E Klon; Jere P Segrest; Stephen C Harvey
Journal:  Biochemistry       Date:  2002-09-10       Impact factor: 3.162

Review 8.  HDL cholesterol and protective factors in atherosclerosis.

Authors:  Gerd Assmann; Antonio M Gotto
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

9.  Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids.

Authors:  Hiroyuki Saito; Padmaja Dhanasekaran; David Nguyen; Els Deridder; Paul Holvoet; Sissel Lund-Katz; Michael C Phillips
Journal:  J Biol Chem       Date:  2004-03-12       Impact factor: 5.157

Review 10.  High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study.

Authors:  Bela F Asztalos
Journal:  Curr Opin Cardiol       Date:  2004-07       Impact factor: 2.161

View more
  10 in total

1.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

2.  4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.

Authors:  Geoffrey D Wool; Veneracion G Cabana; John Lukens; Peter X Shaw; Christoph J Binder; Joseph L Witztum; Catherine A Reardon; Godfrey S Getz
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

3.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality.

Authors:  Nicholas N Lyssenko; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; David Nguyen; Palaniappan Sevugan Chetty; Hiroyuki Saito; Sissel Lund-Katz; Michael C Phillips
Journal:  Biochim Biophys Acta       Date:  2011-08-05

Review 6.  Optimized negative-staining electron microscopy for lipoprotein studies.

Authors:  Lei Zhang; Huimin Tong; Mark Garewal; Gang Ren
Journal:  Biochim Biophys Acta       Date:  2012-09-29

7.  Surface plasmon resonance analysis of the mechanism of binding of apoA-I to high density lipoprotein particles.

Authors:  Sissel Lund-Katz; David Nguyen; Padmaja Dhanasekaran; Momoe Kono; Margaret Nickel; Hiroyuki Saito; Michael C Phillips
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

8.  Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.

Authors:  Geoffrey D Wool; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-03-05       Impact factor: 5.922

9.  Optimized negative staining: a high-throughput protocol for examining small and asymmetric protein structure by electron microscopy.

Authors:  Matthew Rames; Yadong Yu; Gang Ren
Journal:  J Vis Exp       Date:  2014-08-15       Impact factor: 1.355

10.  Interactions of apolipoprotein A-I with high-density lipoprotein particles.

Authors:  David Nguyen; Margaret Nickel; Chiharu Mizuguchi; Hiroyuki Saito; Sissel Lund-Katz; Michael C Phillips
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.